Shanghai, China
Sundia MediTech Co., Ltd. is a prominent pre-clinical contract research organization (CRO) in the biotechnology, health care, and pharmaceutical industries. Established in 2004, the company offers a wide range of high-quality drug discovery and development services, including custom synthesis, library design and synthesis, medicinal chemistry, in vitro and in vivo biology, pre-clinical studies, DMPK, and pharmaceutical development.
Sundia's comprehensive research facilities are situated in Shanghai (Zhangjiang Hi-Tech Park), Shijiazhuang, and Taicang, featuring standard and kilo-labs, an animal facility, a pilot plant, and other supporting facilities. With its experienced R&D and international management team, Sundia has gained recognition for its expertise and diverse service portfolio.
The company received a Venture Round investment from Darwin Venture Management on 01 April 2015, indicating investor confidence in Sundia's potential for growth and innovation. For more information, visit www.sundia.com or email [email protected].
CanAm Bioresearch Inc.